A 12 ferroptosis-related lncRNA prognostic model for HCC stratifies patients into high-risk and low-risk groups, with the high-risk group showing elevated immune checkpoint molecule expressions (PD-1, CTLA-4, CD86). This evidence concerns the gene CD86 and hepatocellular carcinoma.